Product logins

Find logins to all Clarivate products below.


Dialysis Access Treatment Devices – Market Insights – Europe (Supplemental)

Rising uptake percutaneous AVF catheters for dialysis creation and DCBs for dialysis maintenance will support growth in the European dialysis access treatment device market. The rising ESRD population and the launch of novel and innovative premium-priced products will drive market expansion, whereas cost constraints will hinder it to some extent.

This Medtech 360 Report provides high-level market metrics for dialysis access treatment devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Aesthetic Energy-Based Devices – Market Insights – United States
Aesthetic energy-based device procedure volumes will be supported by the trend toward minimally invasive and noninvasive treatments. As a result, companies are investing in developing such devices…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Latin America
The Latin American GI endoscopy devices market is projected to grow moderately through 2034, driven by ongoing innovation in both diagnostic and interventional applications of GI endoscopy…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market is projected to experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…